This paper proposes a pilot decoupling-based two-dimensional channel parameter estimation method for intelligent reflecting surface (IRS)-assisted networks. We exploit the combined effect of Terahertz ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations.

From a technology perspective, Recursion continued the rollout of Recursion OS 2.0, a platform upgrade integrating Exscientia’s AI-driven chemistry capabilities and large-scale multimodal ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $171.9 million in its second quarter.

Recursion Pharmaceuticals is expected to provide updates regarding the clinical-stage pipeline programs on its second-quarter earnings call.

Accurate identification of mechanical parameters holds great significance for optimizing control performance and monitoring working status in permanent magnet synchronous motor (PMSM) drives. This ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks to buy according to hedge funds. Earlier on June 6, a significant advancement in drug discovery was announced with the ...

Prime Intellect has released INTELLECT-2, a 32 billion parameter language model trained using fully asynchronous reinforcement learning across a decentralized network of compute contributors ...

Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025 ...